| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Cash used in operating activities | -4,451 | -3,694 |
| Proceeds from sale of property and equipment | 0 | - |
| Cash provided by investing activities | 0 | - |
| Proceeds from the sale of common stock in private placement | 635 | 635 |
| Cash provided by financing activities | 635 | 635 |
| Net decrease in cash and cash equivalents | -3,816 | -3,059 |
| Cash and cash equivalents at beginning of period | 8,289 | - |
| Cash and cash equivalents at end of period | 4,473 | - |
Galera Therapeutics, Inc. (GRTX)
Galera Therapeutics, Inc. (GRTX)